Why the November 12 Hemp Beverage Ban Could Undermine Harm Reduction
As a healthcare professional working directly with patients, Jonathan "Gio" Stelly argues that Congress should delay the November 12 restrictions on hemp-derived THC beverages and instead pursue a regulatory framework grounded in science, consumer safety, and patient access.
Why the November 12 Hemp Beverage Ban Could Undermine Harm Reduction
The November 12 restrictions on hemp-derived THC beverages may have unintended consequences for public health. Amanda Parker argues that Congress should pursue responsible regulation focused on safety, consumer protection, and harm reduction rather than restricting access to products that many adults use as an alternative to alcohol.
Closing the Gap Between Medical Research and Insurance Coverage for Alternative Treatments
Millions of Americans—including veterans, first responders, seniors, and trauma survivors—face barriers accessing treatments that may improve their quality of life because insurance coverage has not kept pace with scientific research. AACPN's Alternative Care Access Campaign advocates for Medicare, Medicaid, VA, and private insurance policies that incorporate evidence-based alternative and integrative healthcare treatments shown to be safe, effective, and beneficial to patien
